We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Ischemic Preconditioning Ineffectual Before Cardiac Surgery

By HospiMedica International staff writers
Posted on 25 Oct 2015
A new study suggests that cycles of upper arm remote ischemic preconditioning (RIPC) before heart surgery has no effect on outcomes.

Researchers at University Hospital Frankfurt (Germany), University Hospital Göttingen (Germany) and other institutions in Germany conducted a prospective, randomized trial involving 1,385 adults (692 study cohort and 693 shams) scheduled for elective cardiac surgery requiring cardiopulmonary bypass. The primary end point was a composite of death, myocardial infarction (MI), stroke, or acute renal failure up to hospital discharge. Secondary end points included the occurrence of any individual component of the primary end point by day 90.

The results showed no significant between-group difference in the rate of the composite primary end point, or of any of the individual components; the results were similar in the per-protocol analysis, and no treatment effect was found in any subgroup analysis. No significant differences between the RIPC group and the sham-RIPC group were seen in level of troponin release, duration of mechanical ventilation, length of stay in the ICU or the hospital, new onset of atrial fibrillation, and incidence of postoperative delirium. No RIPC-related adverse events were observed. The study was published on October 8, 2015, in the New England Journal of Medicine (NEJM).

“The preconditioning protocol had no impact on the primary composite endpoint of death, MI, stroke, or acute renal failure up to the time of hospital discharge, compared with sham conditioning before elective cardiac surgery requiring cardiopulmonary bypass,” concluded lead author Patrick Meybohm, MD, of University Hospital Frankfurt, and colleagues. “Negative findings did not rule out a possible benefit from other remote ischemic preconditioning protocols, such as those done on lower limbs, with a longer duration of ischemia, or more cycles of preconditioning.”

RIPC involves repetitive cycles of transient ischemia of non-vital tissue to help remote vital organs withstand a subsequent prolonged ischemic event and the eventual reperfusion. It usually consists of 3¬–4 five-minute cycles of right upper arm ischemia, induced by an automated cuff inflated to 200 mmHg, with an intervening five minutes of reperfusion during which the cuff is deflated.

Related Links:

University Hospital Frankfurt
University Hospital Göttingen


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Patient Monitor
IntelliVue MP5SC
New
VTE Prevention System
Flowtron ACS900

Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more